NO943654L - Decorinfragmenter og fremgangsmåter for inhibering av celleregulerende faktorer - Google Patents

Decorinfragmenter og fremgangsmåter for inhibering av celleregulerende faktorer

Info

Publication number
NO943654L
NO943654L NO943654A NO943654A NO943654L NO 943654 L NO943654 L NO 943654L NO 943654 A NO943654 A NO 943654A NO 943654 A NO943654 A NO 943654A NO 943654 L NO943654 L NO 943654L
Authority
NO
Norway
Prior art keywords
cell regulatory
methods
protein
regulatory factors
cell
Prior art date
Application number
NO943654A
Other languages
English (en)
Other versions
NO943654D0 (no
Inventor
Erkki I Ruoslahti
Michael D Pierschbacher
Jose Cardenas
William Scot Craig
Daniel G Mullen
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Publication of NO943654D0 publication Critical patent/NO943654D0/no
Publication of NO943654L publication Critical patent/NO943654L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

Fremgangsmåte for inhibering av en aktivitet av en celleregulerings- faktor som omfatter å bringe celle- reguleringsfaktoren i kontakt med et renset polypeptid, hvor polypeptidet omfatter et cellereguleringsfaktorbin- dende domene fra et protein. Proteinet karakteriseres ved en leucinrik repeti- sjon på tilnærmet 24 aminosyrer. I en spesifikk utførelse gjelder foreligg- ende oppfinnelse evnen til decorin, et protein på 40.000 dalton som vanligvis bærer en glykosaminoglykankjede, og mer spesifikt aktive deoorinfragmenter eller disses funksjonelle ekvivalenter, til å binde TGFp. Oppfinnelsen tilveie- bringer også en ny cellereguleringsfak- tor kalt MRF. Videre tilveiebringes fremgangsmåter for identifisering, på- visning og rensing av celleregulerings- faktorer og proteiner som binder og påvirker aktiviteten av cellereguler- ings faktorer.
NO943654A 1992-04-03 1994-09-30 Decorinfragmenter og fremgangsmåter for inhibering av celleregulerende faktorer NO943654L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86565292A 1992-04-03 1992-04-03
PCT/US1993/003171 WO1993020202A1 (en) 1992-04-03 1993-04-02 Decorin fragments and methods of inhibiting cell regulatory factors

Publications (2)

Publication Number Publication Date
NO943654D0 NO943654D0 (no) 1994-09-30
NO943654L true NO943654L (no) 1994-12-05

Family

ID=25345963

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943654A NO943654L (no) 1992-04-03 1994-09-30 Decorinfragmenter og fremgangsmåter for inhibering av celleregulerende faktorer

Country Status (7)

Country Link
EP (1) EP0636175A1 (no)
JP (1) JPH07508403A (no)
AU (1) AU679178B2 (no)
CA (1) CA2132859A1 (no)
FI (1) FI944575A (no)
NO (1) NO943654L (no)
WO (1) WO1993020202A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69418322D1 (de) * 1993-03-01 1999-06-10 Glycan Pharm Inc Analoge für spezifische oligosaccharid-protein-wechselwirkungen und ihre verwendungen
US5567807A (en) * 1994-07-08 1996-10-22 La Jolla Cancer Research Foundation Processes for the purification of human recombinant decorin and the detection of guanidinium ions
WO2005116066A1 (en) * 2004-05-31 2005-12-08 National University Of Singapore Peptides derived from decorin leucine rich repeats and uses thereof
EP1806359B1 (en) * 2005-09-05 2010-03-17 Immatics Biotechnologies GmbH Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
ES2283212B1 (es) * 2006-03-31 2008-08-16 Lipotec S.A. Peptidos sinteticos utiles en el tratamiento de la piel y su uso en composiciones cosmeticas o dermofarmaceuticas.
HU0700024D0 (en) * 2007-01-11 2007-03-28 Mta Szegedi Biolog Koezpont Use of enhancers in biglycan activuty in the preparation of pharmaceutical compositions having utility in cardiac diseases
EP2538221A3 (en) * 2007-11-05 2013-04-24 Nordic Bioscience A/S Biochemical markers for CVD risk assessment
WO2012125626A2 (en) * 2011-03-14 2012-09-20 Catalent Pharma Solutions Llc Decorin compositions and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991010727A1 (en) * 1990-01-22 1991-07-25 La Jolla Cancer Research Foundation Inhibitors of cell regulatory factors

Also Published As

Publication number Publication date
AU679178B2 (en) 1997-06-26
EP0636175A1 (en) 1995-02-01
CA2132859A1 (en) 1993-10-14
JPH07508403A (ja) 1995-09-21
NO943654D0 (no) 1994-09-30
FI944575A0 (fi) 1994-09-30
FI944575A (fi) 1994-11-29
WO1993020202A1 (en) 1993-10-14
AU4025793A (en) 1993-11-08

Similar Documents

Publication Publication Date Title
NO941821D0 (no) Inhibitorer av cellereguleringsfaktorer samt metoder for forebyggelse eller reduksjon av arrdannelse
NZ501767A (en) Cyclic integrin binding peptide with the amino acid sequence RKK
Jander et al. A collagen-like glycoprotein of the extracellular matrix is the undegraded form of type VI collagen
ATE224713T1 (de) Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression
Lewis et al. The amino acid sequence of rabbit cardiac tropomyosin.
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
IL101728A0 (en) Human notch and delta,binding domains in toporhythmic proteins,and methods based thereon
NO943654L (no) Decorinfragmenter og fremgangsmåter for inhibering av celleregulerende faktorer
NO179412C (no) Hybrid DNA-molekyl som koder for fibronektinbindende protein, mikroorganismer inneholdende slike DNA-molekyler samt fremgangsmåte ved fremstilling av slikt protein
NZ236094A (en) Recombinant protein complex having human factor viii:c activity
Gellerfors et al. Analysis of the Peptide Composition of Purified Beef‐Heart Complex III by Dodecylsulfate Electrophoresis
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
DE69435020D1 (en) Protein-tyrosin-phosphatase ptp-s31
KR960006937A (ko) 사람 인터루킨-6 억제제
NO962084L (no) DNA sekvens som koder for en BMP reseptor
HK1043372A1 (en) Hypoxia-inducible factor 1a hif-1a variants and methods for identifying hif-1a modulators
EP0319315A3 (en) The von willebrand factor binding domain of factor viii
Madsen et al. Analysis of collagen types synthesized by rabbit ear cartilage chondrocytes in vivo and in vitro
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
NO922421L (no) Collagenbindende protein, samt fremstilling derav
DE69837265D1 (de) Polypeptide zur regenerierung des nervensystems
Lester et al. Human alpha-fetoprotein: immunosuppressive activity and microheterogeneity
Ayad et al. Type VI collagen and glycoprotein MFPI are distinct components of the extracellular matrix.
ATE180679T1 (de) Neue verbesserungen hinsichtlich der radiomarkierung von proteinen
WO1997014966B1 (en) Method of activating a novel ligand regulatory pathway